TP53 and neoplasm: Although not yet assessed in anal SCC, clinical trials of treatment of oesophageal SCC with adenovirus-mediated p53 gene transfer in combination with radiotherapy has been associated with improved local tumour control in unresectable tumours (Oohira et al, 2004).